Literature DB >> 9882911

[Is pancreatectomy with resection of the retro-pancreatic vessels for cancer justified?].

J Baulieux1, M Adham, E Oussoultzoglou, E De la Roche, N Berthoux, O Bourdeix, C Ducerf.   

Abstract

AIM OF THE STUDY: Tumoural invasion of the retropancreatic vessels and particularly of the superior mesentericoportal vein confluence (SMPV) is often considered as a contraindication to resection of malignant tumours of the pancreas. The aim of this retrospective study is to report a series of 20 patients and to demonstrate that resection of the vessels supposed to be involved is justified when it is the only barrier to a complete tumoural resection. PATIENTS AND
METHOD: Twenty patients, 11 men and nine women (mean age: 61.7 years) underwent a right (n = 14), left (n = 2) or total (n = 4) pancreatic resection for pancreatic adenocarcinoma (n = 19) or cystadenocarcinoma (n = 1) associated with partial resection of SMPV (n = 17), inferior vena cava (n = 1), right hepatic artery (n = 1) and common hepatic artery (n = 1). The veins were reconstructed in all cases by end to end anastomosis and the arteries by direct suture in one patient and venous or artery graft in two patients.
RESULTS: Tumoural invasion was histologically present in the vascular wall in nine patients, in the perivascular area in six and negative in five. The in-hospital mortality was nil. One patient had an early venous thrombosis of the repaired SMPV which was reoperated and treated with success by desobstruction and venous graft. The 3-year actuarial survival rate was 16%.
CONCLUSION: Segmental venous resection of the SMPV confluence can be performed safely. Localised invasion of the vascular wall, considered as the only obstacle for a complete tumoural resection, is not associated with a poor prognosis. In case of tight adhesions between tumour and SMPV (inflammatory or tumoural) the venous resection may be included in a deliberate surgical strategy. On the other hand, total obstruction of SMPV, extrapancreatic tumoural extension, tumoural invasion of superior mesenteric artery or coeliac trunk are contraindications to pancreatic resection.

Entities:  

Mesh:

Year:  1998        PMID: 9882911     DOI: 10.1016/s0001-4001(99)80069-5

Source DB:  PubMed          Journal:  Chirurgie        ISSN: 0001-4001


  8 in total

Review 1.  Multidisciplinary management of locally advanced-borderline resectable adenocarcinoma of the head of the pancreas.

Authors:  F Calvo; C Guillen Ponce; M Muñoz Beltran; A Sanjuanbenito Dehesa
Journal:  Clin Transl Oncol       Date:  2012-11-21       Impact factor: 3.405

2.  [Reconstruction of visceral arteries with homografts in excision of the pancreas].

Authors:  U Settmacher; J M Langrehr; I Husmann; R Eisele; M Bahra; M Heise; P Neuhaus
Journal:  Chirurg       Date:  2004-12       Impact factor: 0.955

3.  Results of vascular resections during pancreatectomy from two European centres: an analysis of survival and disease-free survival explicative factors.

Authors:  M Adham; D F Mirza; F Chapuis; A D Mayer; S R Bramhall; C Coldham; J Baulieux; J Buckels
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

4.  Escalating computed tomography angiogram (CTA) grade predicts unresectability and margin status for pancreaticobiliary neoplasms.

Authors:  Tara S Kent; Vassilios Raptopoulos; Mark P Callery; Shiva Gautam; Charles M Vollmer
Journal:  HPB (Oxford)       Date:  2010-03       Impact factor: 3.647

5.  Splenic and portal vein thrombosis in pancreatic metastasis from renal cell carcinoma.

Authors:  Shailesh V Shrikhande; Peter Büchler; Irene Esposito; Martin Loos; Markus W Büchler; Helmut Friess
Journal:  World J Surg Oncol       Date:  2006-05-17       Impact factor: 2.754

6.  Posterior versus standard approach in pancreatoduodenectomy: a case-match study.

Authors:  Traian Dumitrascu; Leonard David; Irinel Popescu
Journal:  Langenbecks Arch Surg       Date:  2009-05-06       Impact factor: 3.445

7.  Controversies in the management of borderline resectable proximal pancreatic adenocarcinoma with vascular involvement.

Authors:  Olga N Tucker; Mohamed Rela
Journal:  HPB Surg       Date:  2009-03-11

8.  Therapeutic anticoagulant does not modify thromboses rate vein after venous reconstruction following pancreaticoduodenectomy.

Authors:  Mehdi Ouaïssi; Igor Sielezneff; Nicolas Pirro; Rémi Bon Mardion; Jean Batiste Chaix; Abdelrhame Merad; Stéphane Berdah; Vincent Moutardier; Silvia Cresti; Olivier Emungania; Loundou Anderson; Brunet Christian; Sastre Bernard
Journal:  Gastroenterol Res Pract       Date:  2008-11-23       Impact factor: 2.260

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.